Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indirubin derivatives and uses thereof in treating chronic myelogenous leukemia

Indirubin derivatives and uses thereof in treating chronic myelogenous leukemia

US Patent 9512076 · Granted Dec 6, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-Bromo-indirubins2024
T-cell lymphoma treatments2023
Dithio ETP derivatives2023
Indirubin derivatives, and uses thereof2022
Indirubin derivatives, and uses thereof2022
5-bromo-indirubins2022
Thioindirubins2022
Methods and compositions for the treatment of cancer or other diseases2021
Pyridopyrazine compounds and uses thereof2021
Pyridopyrazine compounds and uses thereof2021
Dithio ETP derivatives2020
5-bromo-indirubins2020